Task B1: Phase I Clinical Trial of a Therapeutic for Gram Negative and Positive Bacteria Infection
$238,891N01FY2023AINIH
Dynport Vaccine Company, Llc, Frederick MD
Investigators
Abstract
The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic agents for the treatment of infectious disease.
View original record on NIH RePORTER →